Performance Measures:
Measures We Do Not Support: Not Tested
- Group/Practice
- Individual Clinician
- Health Plan
Osteoporosis Management in Women who had a Fracture
The percentage of women 50–85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat osteoporosis in the six months after the fracture.
Date Reviewed: May 4, 2022
- Group/Practice
- Individual Clinician
Screening for Osteoporosis for Men Aged 70 Years and Older
Percentage of male patients aged 70 years and older who had a central dual-energy X-ray absorptiometry (DXA) to screen for osteoporosisDate Reviewed: May 4, 2022
- Group/Practice
- Individual Clinician
Vitamin D Level - Effective Control of Low Bone Mass/Osteopenia and Osteoporosis: Therapeutic Level Of 25 OH Vitamin D Level Achieved
Percentage of patients aged 65 years and older diagnosed with osteopenia or osteoporosis whose most recent serum 25 Hydroxy-Vitamin D results is greater than or equal to 30.0 ng/dLDate Reviewed: May 4, 2022
- Group/Practice
- Individual Clinician
Depression Remission at Twelve Months
The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60 days) after an index event date.
Date Reviewed: September 28, 2022
- Health Plan
- Group/Practice
- Individual Clinician
Anti-Depressant Medication Management
"Percentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment. Two rates are reported.
a. Percentage of patients who remained on an antidepressant medication for at least 84 days (12 weeks).
b. Percentage of patients who remained on an antidepressant medication for at least 180 days (6 months).
Date Reviewed: September 28, 2022